ABOUT THIS FEED
The AI in Medicine RSS feed, currently aggregated through a library portal, focuses on the growing role of artificial intelligence in healthcare. Articles in this feed highlight clinical applications such as diagnostic imaging, predictive analytics, drug discovery, and personalized medicine. Readers can expect updates on both academic research and practical deployments in hospitals and health systems. While still serving as a stand-in until more specialized feeds are available, it offers valuable insights into how AI is transforming medical practice. With posts appearing several times per week, the feed is particularly useful for clinicians, researchers, and healthcare professionals seeking to understand the practical benefits and challenges of adopting AI in medicine. It provides a focused lens on one of the most impactful domains of AI application.
- Global Burden of Lead-Attributable Cardiovascular Disease
This study assesses the association between bone lead levels and cardiovascular disease (CVD) and estimates global, regional, and national lead-attributable CVD burden for 1990 to 2023.
- Reframing the Coronary Heart Disease Epidemic—The Role of Lead Exposure
In the 1912 edition of The Principles and Practice of Medicine, William Osler described angina pectoris as serious but uncommon and observed that chronic lead intoxication played “an important role in the causation of arteriosclerosis.” Coronary thrombosis was not yet the defining illness of modern life. Within a few decades—during the age of industrial combustion and the rise of leaded gasoline—coronary heart disease became the leading cause of death in the US.
- Limitations of Knowledge of Benefit or Harm of Cannabis and Cannabinoids Use
To the Editor The recent Review by Dr Hsu and colleagues indicates that evidence from randomized clinical trials does not support the use of cannabis or cannabinoids for most conditions for which it is promoted. Despite this evidence, states and medical boards have increasingly sanctioned the use of cannabis for medical needs, and state medical boards, medical professionals, medical publications, the cannabis industry, and laypeople often refer to such sanctioned use of cannabis as medical marijuana.
- Audio Highlights April 3, 2026
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.
- WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults
To the Editor We believe the recent WHO guidelines on GLP-1 receptor agonists for weight management present pragmatic limitations that distance it from real-world clinical practice.
- Caffeinated Coffee and Atrial Fibrillation
To the Editor A recent trial showed that caffeinated coffee consumption reduced AF/atrial flutter burden over 6 months compared with caffeine abstinence. However, extrapolating these benefits to “other caffeinated products” warrants caution and may pose a public health risk. In this study, energy drinks accounted for 5% or less of caffeine sources.
- Caffeinated Coffee and Atrial Fibrillation—Reply
In Reply We thank the Letter authors for their thoughtful suggestions and questions about our recent DECAF trial.
- GLP-1 and GIP Drugs Before Endoscopy May Raise Residual Gastric Volume Risk
Continuing to take a glucagon-like peptide-1 (GLP-1) or a GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist prior to upper endoscopy appeared to increase risk of clinically significant residual gastric volume, a randomized clinical trial found.
- Many Medical Schools to Increase Nutrition Training Under New Initiative
This Medical News article discusses an initiative from the US Department of Health and Human Services to increase nutrition training for physicians.
- Higher Cancer Mortality Rates Have Shifted From Urban to Rural Areas in US
The highest cancer mortality rates in the US have shifted from urban to rural areas over the past 50 years, according to recent findings.